The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration
- PMID: 17021315
- DOI: 10.1056/NEJMp068185
The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration
Comment on
-
Ranibizumab for neovascular age-related macular degeneration.N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481. N Engl J Med. 2006. PMID: 17021318 Clinical Trial.
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical